| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/26/2000 | EP0973794A1 Netrin receptors |
| 01/26/2000 | EP0973550A1 Antagonistic anti-avb3 integrin antibodies |
| 01/26/2000 | EP0973549A2 Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties |
| 01/26/2000 | EP0973547A1 Improving binding affinity of antigenic peptides for mhc molecules |
| 01/26/2000 | EP0973537A1 Cocaethylene immunogens and antibodies |
| 01/26/2000 | EP0800649A4 Inhibition of glial cell proliferation |
| 01/26/2000 | EP0743870B1 Preparation and application of artificial anti-idiotypic imprints |
| 01/26/2000 | EP0700305B1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
| 01/26/2000 | EP0587735B1 T cell receptor peptides as therapeutics for immune-related disease |
| 01/26/2000 | CN1242802A Notch protein and their ligands |
| 01/26/2000 | CN1048731C Polynucleotide of drug binding protein as coded CSAID |
| 01/25/2000 | US6018032 A monoclonal antibody capable of binding to an epitope and neutralizing interleukin receptor; diagnosis and therapy for chronic bronchial asthma; antiasthmatic agent |
| 01/25/2000 | US6018031 Binding agents specific for IgA receptor |
| 01/25/2000 | US6018026 For rapid, inexpensive and adaptable high volume screening of ligands to receptors; for determining the presence of cell growth factors in samples; for purifying cell growth factors and isoforms |
| 01/25/2000 | US6018024 A soluble fragment of amyloid protein having the carboxy terminal methionine or leucine amino acid resulting from cleavage of the intact protein; diagnosis and therapy for alzheimer's disease |
| 01/25/2000 | US6018023 Kainate-binding, human CNS receptors of the EAA3 family |
| 01/25/2000 | US6018019 Immunogenic synthetic peptides which are useful alone or in conjugates in vaccines against hemophilus influenza infection |
| 01/25/2000 | US6017886 Use of NDF peptide as growth factor for sensory epithelium |
| 01/25/2000 | US6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/25/2000 | US6017759 Chimeric infectious bursal disease virus cDNA clones, expression products and vaccines based thereon |
| 01/25/2000 | US6017757 A homogenous cell population of parasitic cells obtained by in-vitro culturing of differentiated intestinal cells of a nematode; therapy and prevention of parasitic infections in animals |
| 01/25/2000 | US6017754 Eukaryotic expression vector of linked dna sequences encoding anti-4-ethoxymethylene-2-phenyl-2-oxazolin-5-one single-chain antibody, transmembrane domain, signal sequence, and protein; screening of cell cultures within hours of transfection |
| 01/25/2000 | US6017733 Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same |
| 01/25/2000 | US6017732 To screen for enhanced specfic binding pair binding |
| 01/25/2000 | US6017729 Receptor activator of NF-κB |
| 01/25/2000 | US6017728 ribH |
| 01/25/2000 | US6017719 Targeting cells from heterogeneous suspension; forming cell complexes linked to antibody bound to surface antigen, separating complexes, mixing antibody with peptide that binds and displaces antibody from antigen, releasing target cell |
| 01/25/2000 | US6017717 Human thymosin β15 gene, protein and uses thereof |
| 01/25/2000 | US6017695 A polynucleotide sequence that encodes a human brain glycoprotein, contactin; to study signal transmissions, cell morphology, cell metabolism and cell adhesion |
| 01/25/2000 | US6017541 Methyl ecgonine phenylphosphonates as analogues of transition states for the hydrolysis of the benzoyl ester of an ecgonine derivative, namely cocaine, and their linking to carrier proteins for use as immunogens |
| 01/25/2000 | US6017514 Contacting a labeled antibody specific to an internal cell component but not with external ones with tissue of a mammal that has received therapy to kill malignant cells; measuring the binding where the internal component is an antigen |
| 01/25/2000 | CA2190268C Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood |
| 01/25/2000 | CA2031504C Monoclonal antibodies to c-reactive protein |
| 01/25/2000 | CA1340880C Cancer-related antigen-specific human immunoglobulins and human/human hybridomas having the ability to produce said human immunoglobulins |
| 01/25/2000 | CA1340879C Recombinant dna product and methods |
| 01/20/2000 | WO2000003036A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | WO2000003024A2 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 01/20/2000 | WO2000003023A1 Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex |
| 01/20/2000 | WO2000003016A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | WO2000003015A2 Human transport protein homologs |
| 01/20/2000 | WO2000002925A1 Lupus anticoagulant antibody to f1 region of prothrombin |
| 01/20/2000 | WO2000002924A1 Papillomavirus cellular receptor |
| 01/20/2000 | WO2000002923A1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 01/20/2000 | WO2000002922A1 Antibody against protein tyrosine phosphatase intracellular domains |
| 01/20/2000 | WO2000002917A2 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | WO2000002913A1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use |
| 01/20/2000 | WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/20/2000 | WO2000002902A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | WO2000002897A2 Delta cleavage products and methods based thereon |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002587A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 01/20/2000 | WO2000002584A2 Cancer treatment methods using antibodies to aminophospholipids |
| 01/20/2000 | WO2000002583A1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 01/20/2000 | WO2000002582A2 Treatment of celiac disease with interleukin-15 antagonists |
| 01/20/2000 | WO1999059633A8 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 01/20/2000 | WO1999058676A3 Semaphorin polypeptides |
| 01/20/2000 | WO1999058641A8 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 01/20/2000 | WO1999058559A3 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 01/20/2000 | WO1999051742A3 Dadd, death activator death domain protein |
| 01/20/2000 | WO1999049037A3 Protein phosphatase-related molecules |
| 01/20/2000 | WO1999048927A9 Methods for designing specific ion channel blockers |
| 01/20/2000 | WO1999048916A3 Hypoxia-inducible human genes, proteins, and uses thereof |
| 01/20/2000 | WO1999047674A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/20/2000 | WO1999046288A3 A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 01/20/2000 | WO1999040115A9 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT |
| 01/20/2000 | WO1998042376A9 Composition comprising immunoglobulin |
| 01/20/2000 | CA2337438A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | CA2337101A1 Papillomavirus cellular receptor |
| 01/20/2000 | CA2335382A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | CA2335090A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | CA2334078A1 Lupus anticoagulant antibody to f1 region of prothrombin |
| 01/20/2000 | CA2333928A1 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | CA2333923A1 Treatment of celiac disease with interleukin-15 antagonists |
| 01/20/2000 | CA2333898A1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use |
| 01/20/2000 | CA2333893A1 Delta cleavage products and methods based thereon |
| 01/20/2000 | CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon) |
| 01/20/2000 | CA2332346A1 Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex |
| 01/20/2000 | CA2332307A1 Human transport protein homologs |
| 01/20/2000 | CA2331789A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 01/19/2000 | EP0972837A2 Ubiquitin specific protease like protein |
| 01/19/2000 | EP0972782A1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 01/19/2000 | EP0972781A1 Proteins polypeptides and uses thereof |
| 01/19/2000 | EP0972524A1 Lymphocyte activation inhibitors |
| 01/19/2000 | EP0972521A1 Pharmaceutical composition containing stimulators of interferon-gamma |
| 01/19/2000 | EP0972445A1 Pluripotent cells having disrupted intrinsic genes |
| 01/19/2000 | EP0972201A2 Compounds for immunodiagnosis of prostate cancer and methods for their use |
| 01/19/2000 | EP0972199A1 Method of detecting antigen-specific t-cells |
| 01/19/2000 | EP0972198A1 Method for simultaneous detection of hiv antigens and hiv antibodies |
| 01/19/2000 | EP0972183A1 Methods for concentrating ligands using magnetic particles |
| 01/19/2000 | EP0972062A2 Plant pest control |
| 01/19/2000 | EP0972056A1 Reagents and methods useful for detecting diseases of the lung |
| 01/19/2000 | EP0972054A1 Enhancement of immune response using targeting molecules |
| 01/19/2000 | EP0972053A1 Novel human serine carboxypeptidase |
| 01/19/2000 | EP0972052A1 Keratinocyte derived kallikrein |
| 01/19/2000 | EP0972048A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 01/19/2000 | EP0972047A2 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination |
| 01/19/2000 | EP0972045A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
| 01/19/2000 | EP0972042A1 Polypeptide expressed in the horny layer of epidermis and use thereof |
| 01/19/2000 | EP0972041A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |